akr-501 and Hearing-Loss--Sensorineural

akr-501 has been researched along with Hearing-Loss--Sensorineural* in 1 studies

Other Studies

1 other study(ies) available for akr-501 and Hearing-Loss--Sensorineural

Article	Year
Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure. Platelets, 2022, Nov-17, Volume: 33, Issue:8 MYH9-related disorder (MYH9-RD) is autosomal dominant thrombocytopenia caused by mutations in the Topics: Benzoates; Hearing Loss, Sensorineural; Humans; Hydrazines; Male; Molecular Motor Proteins; Mutation; Myosin Heavy Chains; Pyrazoles; Thiazoles; Thiophenes; Thrombocytopenia; Treatment Failure	2022

Article

Year

Avatrombopag improves thrombocytopenia in MYH9-related disorder following eltrombopag treatment failure.

Platelets, 2022, Nov-17, Volume: 33, Issue:8

MYH9-related disorder (MYH9-RD) is autosomal dominant thrombocytopenia caused by mutations in the

Topics: Benzoates; Hearing Loss, Sensorineural; Humans; Hydrazines; Male; Molecular Motor Proteins; Mutation; Myosin Heavy Chains; Pyrazoles; Thiazoles; Thiophenes; Thrombocytopenia; Treatment Failure

2022